Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ESSA Pharma Inc. | Director | Common Shares | 43.2K | $212K | $4.90 | Apr 24, 2024 | Direct |
enGene Holdings Inc. | Director | Common Shares | 24.7K | $22K | $0.89 | May 28, 2024 | Direct |
enGene Holdings Inc. | Director | Stock Option (Right to Buy) | 20K | Jun 15, 2024 | Direct | ||
ESSA Pharma Inc. | Director | Options | 0 | Apr 24, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ENGN | enGene Holdings Inc. | Jun 15, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Director |
ENGN | enGene Holdings Inc. | May 28, 2024 | 2 | $107 | 4 | May 29, 2024 | Director |
EPIX | ESSA Pharma Inc. | Apr 24, 2024 | 2 | $18.4K | 4 | Apr 25, 2024 | Director |
EPIX | ESSA Pharma Inc. | Mar 25, 2024 | 1 | $0 | 4 | Mar 28, 2024 | Director |
ENGN | enGene Holdings Inc. | Oct 31, 2023 | 9 | $0 | 4 | Nov 2, 2023 | Director |
ENGN | enGene Holdings Inc. | Oct 31, 2023 | 0 | $0 | 3 | Oct 31, 2023 | Director |
EPIX | ESSA Pharma Inc. | Jun 29, 2022 | 1 | $0 | 4 | Nov 1, 2022 | Director |